Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-04

FDA Approved: CHLORTHALIDONE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved an original application for chlorthalidone from Lifestar Pharma LLC, a generic diuretic indicated for hypertension and edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)

Snippet

ORIG AP for CHLORTHALIDONE (CHLORTHALIDONE)